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Leon E. Rosenberg
To many people in the scientiﬁc community, and to
manymore in the lay community beyond, the name Fran-
cis Collins is synonymous with the successful completion
of the Human Genome Project. His contributions to this
monumental undertaking have been singular, and they
have been duly recognized—up to and including a Rose
Garden visit at the White House with President Clinton
and Francis’s archrival, Craig Venter (often caricaturedand
maligned as the scientiﬁc equivalent of Darth Vader).
Because Francis is so identiﬁed with the Genome Project
and has so brilliantly led the National Human Genome
Research Institute at NIH for the past 12 years, some may
think his scientiﬁc achievements are contemporaneous
with, and restricted to, the project. But those of us in the
human genetics community old enough to know better,
well, know better. The Awards Committee of ASHG was
unanimous in selecting Francis Collins as the 2005 recip-
ient of the coveted William Allan Award, because it knows
that Francis’s career epitomizes the designation of that
award: “for substantial scientiﬁc contributions to human
and medical genetics carried out over a lifetime of scien-
tiﬁc inquiry.”
Our honoree was raised on a small farm in Virginia. He
obtained his undergraduate degree in chemistry at the
University of Virginia, then went on to earn a Ph.D. in
physical chemistry at Yale University in 1974, at age 24.
There, he became aware that a revolution was beginning
inmolecular biology and genetics, so he decided to change
ﬁelds and went to medical school at the University of
North Carolina in Chapel Hill, where he earned the M.D.
degree in 1977. During 3 subsequent years as a resident
in internal medicine, Francis, whose ﬁrst fascination with
human genetics came during his ﬁrst year of medical
school, clinched his resolve for a career in humangenetics.
I met Francis in 1980 during his interview for a post-
doctoral fellowship in Human Genetics at Yale. He was
30. Not surprisingly, he greatly impressed me and all the
other faculty who met him, and I was delighted when he
took my advice and came to our department. I was not
so thrilled when he failed to take my advice and join my
laboratory group. This was to be the ﬁrst of three signif-
icant times over the next 13 years that Francis sought my
advice and did otherwise. No one—including my chil-
dren—has so regularly asked for, then spurned, my coun-
sel. But more of that micro-rant later.
Francis chose to work with ShermanWeissman, inwhose
laboratory he cut his scientiﬁc teeth on the then-only ro-
bust human molecular genetics model, hemoglobin. He
published on thalassemia and hereditary persistence of
fetal hemoglobin, but his ﬁrst groundbreaking scientiﬁc
publication appeared in 1984 in the Proceedings of the Na-
tional Academy of Sciences, entitled “Directional Cloning of
DNA Fragments at a Large Distance from an Initial Probe:
A Circularization Method” (Proc Natl Acad Sci USA 81:
6812–6816). This was the dawn of “chromosome jump-
ing,” a technique crucial to the term “positional cloning,”
which Francis Collins coined soon thereafter.
Francis was a fabulous clinical fellow as well. His diag-
nostic skill, patient and family rapport, and case presen-
tations were the best I’d ever heard. It should come as no
surprise then, that I advised Francis to join our faculty in
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1984, only to have him demur again and go to the Uni-
versity of Michigan in Ann Arbor.
For the next 9 years, his laboratory perfected and used
positional-cloning techniques to identify disease genes in
the absence of functional correlates. His group discovered,
or collaborated in the discovery of, several important genes,
including those responsible for cystic ﬁbrosis, neuroﬁbro-
matosis type 1, andHuntington disease. These discoveries,
and those of many other investigators, established posi-
tional cloning as an unusually powerful tool in disease-
gene ﬁnding, superseding functional cloning in scale and
applicability.
In 1992, while his scientiﬁc prowess was at full throttle,
Francis again sought my advice. What did I think of the
idea, he asked, of his becoming the director of the Human
Genome Research Center at NIH. Having been a member
of the NRC committee that recommended to Congress
that the U.S. undertake the Human Genome Project and
having seen the overpowering James Watson become its
ﬁrst NIH steward and having heard that Watson had re-
signed in a huff because he had no respect for the Director
of NIH, Bernadine Healy, and having watched Francis Col-
lins ascend the ladder of scientiﬁc prominence remarkably
quickly, I advised him to avoid the political maelstrom at
NIH and stay in the safe harbor of Ann Arbor.
Of course, he took the job at NIH and has been a stellar
leader of the Center, now Institute, ever since. He has even
continued to lead his own laboratory, whose most impor-
tant recent achievement has been the identiﬁcation of the
gene for the Hutchinson-Gilford progeria syndrome.
Francis Collins has made contributions beyond science.
He has coauthored, with Tom Gelehrter and David Gins-
burg, two editions of a leading textbook on medical ge-
netics. He has written widely on the future of genomics
in clinical medicine. He has been vocal and persistent in
his emphasis on the importance of ethical and legal issues
in genetics and genomics—particularly those concerned
with the privacy of genetic information and the prohi-
bition of gene-based discrimination in employment and
health insurance.
It occurs to me that I should continue to try to age
gracefully and healthily for all the usual reasonspertaining
to family, friends, and work, but for an unusual reason as
well. You see, Francis is only 55 years old, and who knows
how many more times he may seek my advice and do the
opposite, thereby ﬁnding personal fulﬁllment while en-
riching science, medicine, and humankind.
Francis, it is a privilege to know you and to present you
with the William Allan Award on behalf of the American
Society of Human Genetics.
